STOCKWATCH

Gujarat Themis Biosyn Ltd Withdraws Scheme of Amalgamation with Themis Medicare Ltd

Gujarat Themis Biosyn Ltd has decided to withdraw its Scheme of Amalgamation with Themis Medicare Ltd. The decision was made after the company evaluated new market developments and decided to focus on its core business of Fermentation based Pharmaceutical Intermediates and Active Pharmaceutical Ingredients. The company sees significant opportunities for organic expansion and possible inorganic growth in this sector. This decision allows the company to leverage its core strengths in the Fermentation and Active Pharmaceutical Ingredients based businesses.

• Gujarat Themis Biosyn Ltd withdraws Scheme of Amalgamation with Themis Medicare Ltd
• Company to focus on core business of Fermentation based Pharmaceutical Intermediates and Active Pharmaceutical Ingredients
• Significant opportunities for organic and possible inorganic growth seen in the sector
• Decision allows company to leverage core strengths in Fermentation and Active Pharmaceutical Ingredients based businesses